James Peter Burnie

This inventor holds 14 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Neutec Pharma Limited, The University of Manchester, Neutech Pharma Plc. Active years: 1994-2010.

USPTO Granted Patents = 14 (Patent Applications = 2)

% Patents Active = 64.3

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 90(Granted Patents)

Location History:

Wilmslow, GB (1994 - 1998)
Alderley Edge, GB (1999 - 2006)
Manchester, GB (2009 - 2010)

Company Filing History:

10 out of 10

Neutec Pharma Limited

patents

3 out of 233

The University of Manchester

Years Active: 1994-2010

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7785571 - Treatment of fungal infections (2010-08-31),

2. 7608265 - Treatment for bacterial infections (2009-10-27),

3. 7132512 - Medicament for the treatment of chlamydial infection (2006-11-07),

4. 7037495 - Antimicrobial compositions (2006-05-02),

5. 6881410 - Treatment of E. faecium infection (2005-04-19),

6. 6627730 - Staphylococcal ABC transporter protein (2003-09-30),

7. 6544516 - Treatment and diagnosis of infections of gram positive cocci (2003-04-08),

8. 6410024 - Epitopes of shigella like toxin and their use as vaccine and in diagnosis (2002-06-25),

9. 6039959 - Treatment and diagnosis of infections due to helicobacter pylori (2000-03-21),

10. 5861157 - Diagnosis and treatment of infections due to Streptococci and Enterococci (1999-01-19),

11. 5777083 - Stress protein epitopes (1998-07-07),

12. 5686248 - Fungal stress proteins (1997-11-11),

13. 5541077 - Fungal stress proteins (1996-07-30),

14. 5288639 - Fungal stress proteins (1994-02-22),

Title: James Peter Burnie - A Pioneer in Medical Innovations

Introduction

James Peter Burnie, an accomplished inventor based in Alderley Edge, Great Britain, has made significant contributions to the fields of medicine and biotechnology. With a remarkable portfolio of 14 patents, Burnie's innovations focus on combating infectious diseases through novel treatments and compositions.

Latest Patents

Among his latest patents are two groundbreaking inventions aimed at treating infections. The first patent pertains to the treatment of fungal infections, where he has developed a composition comprising an antibody or an antigen binding fragment specific for at least one epitope of hsp90 from an organism of the genus, alongside potent antifungal agents such as itraconazole and voriconazole. His second patent addresses bacterial infections, introducing new compounds, medicaments, and treatments together with novel isolated antibodies. This invention targets both the treatment and prophylaxis of such infections, showcasing Burnie's dedication to enhancing healthcare solutions.

Career Highlights

Throughout his career, James Peter Burnie has worked with esteemed organizations, including Neutec Pharma Limited and The Victoria University of Manchester. His tenure in these institutions has allowed him to collaborate with leading experts, push the boundaries of medical research, and drive innovative solutions in infectious disease treatment.

Collaborations

In his journey, Burnie has collaborated with accomplished professionals such as Ruth Christine Matthews and Tracey Carter. These partnerships have fostered a dynamic exchange of ideas and expertise, resulting in significant advancements in their respective fields.

Conclusion

James Peter Burnie's contributions to medical innovations exemplify the power of inventive thinking in addressing pressing health challenges. His ongoing dedication to research and development continues to inspire future generations of inventors and researchers aiming to make a difference in the world of medicine.